Publications 2024

Liu Y, Peng C, Brorson IS, O'Mahony DG, Kelly RL, Heng YJ, Baker GM, Grenaker Alnæs GI, Bodelon C, Stover DG, Van Allen EM, Eliassen AH, Kristensen VN, Tamimi RM, Kraft P (2024)
Germline polygenic risk scores are associated with immune gene expression signature and immune cell infiltration in breast cancer
Am J Hum Genet, 111 (10), 2150-2163
DOI 10.1016/j.ajhg.2024.08.009, PubMed 39270649

Publications 2023

O'Mahony DG, Ramus SJ, Southey MC, Meagher NS, Hadjisavvas A, John EM, Hamann U, Imyanitov EN, Andrulis IL, Sharma P, Daly MB, Hake CR, Weitzel JN, Jakubowska A, Godwin AK, Arason A, Bane A, Simard J, Soucy P, Caligo MA, Mai PL, Claes KBM, Teixeira MR, Chung WK, Lazaro C et al. (2023)
Ovarian cancer pathology characteristics as predictors of variant pathogenicity in BRCA1 and BRCA2
Br J Cancer, 128 (12), 2283-2294
DOI 10.1038/s41416-023-02263-5, PubMed 37076566

Zanti M, Loizidou MA, O'Mahony DG, Dorling L, Dennis J, Devilee P, Easton DF, Panayiotidis MI, Hadjisavvas A, Michailidou K (2023)
Multi-gene panel testing and association analysis in Cypriot breast cancer cases and controls
Front Genet, 14, 1248492
DOI 10.3389/fgene.2023.1248492, PubMed 37790698

Zanti M, O'Mahony DG, Parsons MT, Li H, Dennis J, Aittomäkkiki K, Andrulis IL, Anton-Culver H, Aronson KJ, Augustinsson A, Becher H, Bojesen SE, Bolla MK, Brenner H, Brown MA, Buys SS, Canzian F, Caputo SM, Castelao JE, Chang-Claude J, GC-HBOC study Collaborators, Czene K, Daly MB, De Nicolo A, Devilee P et al. (2023)
A likelihood ratio approach for utilizing case-control data in the clinical classification of rare sequence variants: application to BRCA1 and BRCA2
Hum Mutat, 2023
DOI 10.1155/2023/9961341, PubMed 38725546